BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Asia Recalls Merck Sharp & Dohme (MRK)'s Contraceptive Devices


3/26/2013 7:44:43 AM

Hong Kong (HKSAR) - The Department of Health (DH) today (March 26) instructed a local medical device supplier, Merck Sharp & Dohme (Asia) Limited to recall one lot of Multiload Radiopaque Cu375 intrauterine contraceptive devices (IUCDs), manufactured by an Irish company, Multilan AG, following discovery of impurities inside the packing of a number of devices.

The discovery was made by DH's Family Health Service (FHS) when they conducted routine inspection of stock prior to distributing the devices for use by their Maternal and Child Health Centres (MCHCs).

Among some 300 IUCDs inspected belonging to lot number SM-3337-13, 4 devices were found to contain tiny hair-like or dust-like impurities inside their sterile pouches. So far, MCHCs have not used IUCDs from the affected lot.

The FHS reported the issue to the supplier as well as the Medical Device Control Office, which began investigation immediately.

According to the supplier, about 950 devices from the affected lot were distributed to public and private hospitals and some private clinics. The DH has not received any relevant report of adverse incidents in Hong Kong.

As a precautionary measure, the supplier is instructed to conduct a batch recall of the product with lot number SM-3337-13 from the market.

The supplier has set up a hotline (3971 2913) for enquiries.

Healthcare professionals should stop using the affected products immediately. DH has brought the matter to relevant stakeholders' attention and will follow up on the investigation.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES